Article
Engineered probiotic <i>Escherichia coli</i> -mediated intestinal nicotine clearance alleviates nonalcoholic steatohepatitis in mice
2026-07-03
Abstract excerpt
Nicotine accumulates in the gut and drives non-alcoholic steatohepatitis (NASH) via the gut-liver axis, yet no effective clinical intervention is currently available. To address this challenge, the probiotic Escherichia coli Nissle 1917 (EcN) was engineered for in situ nicotine clearance in the gut. Mutational screening of nicotine oxidoreductase 2 (PpNicA2) identified a highly active variant, PpNicA2 A107R . It...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 91980e71-c320-57e0-8d4c-5b54da939b9f
- DOI
- 10.64898/2026.07.02.736048
